68 related articles for article (PubMed ID: 7332440)
1. [Serum somatomedin activity in children after surgery for craniopharyngioma (authors transl)].
Martinez MJ; Chaussain JL; Schimpff RM; Donnadieu M; Roger M; Job JC
Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():881-6. PubMed ID: 7332440
[TBL] [Abstract][Full Text] [Related]
2. Postoperative pituitary hormonal disturbances and hormone replacement therapy time and dosage in children with craniopharyngiomas.
Li GM; Sun XJ; Shao P
Chin Med J (Engl); 2008 Oct; 121(20):2077-82. PubMed ID: 19080279
[TBL] [Abstract][Full Text] [Related]
3. Craniopharyngioma: the role of insulin in promoting postoperative growth.
Costin G; Kogut MD; Phillips LS; Daughaday WH
J Clin Endocrinol Metab; 1976 Feb; 42(2):370-9. PubMed ID: 1262435
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
[TBL] [Abstract][Full Text] [Related]
5. Impaired growth hormone secretion in patients operated for pituitary adenomas.
Hoeck HC; Bang F; Laurberg P
Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
[TBL] [Abstract][Full Text] [Related]
6. Growth in children with a craniopharyngioma.
Blethen SL
Pediatrician; 1987; 14(4):242-5. PubMed ID: 2840646
[TBL] [Abstract][Full Text] [Related]
7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
8. Abnormal regulation of thirst and vasopressin secretion following surgery for craniopharyngioma.
Smith D; Finucane F; Phillips J; Baylis PH; Finucane J; Tormey W; Thompson CJ
Clin Endocrinol (Oxf); 2004 Aug; 61(2):273-9. PubMed ID: 15272926
[TBL] [Abstract][Full Text] [Related]
9. [Somatomedin activity of the serum in the normal child and in hypopituitarism].
Binet E; Schlumberger A; Chaussain JL; Job JC
Arch Fr Pediatr; 1974 Apr; 31(4):339-46. PubMed ID: 4368260
[No Abstract] [Full Text] [Related]
10. Changes of hypothalamus-pituitary hormones in patients after total removal of craniopharyngiomas.
Zhou ZQ; Shi XE
Chin Med J (Engl); 2004 Mar; 117(3):357-60. PubMed ID: 15043773
[TBL] [Abstract][Full Text] [Related]
11. Somatomedin in children with chronic renal insufficiency - relationship to growth rate and energy intake.
Arnold WC; Uthne K; Spencer EM; Piel C; Holliday MA
Int J Pediatr Nephrol; 1983 Mar; 4(1):29-34. PubMed ID: 6853038
[TBL] [Abstract][Full Text] [Related]
12. Raised somatomedin activity in the serum of young boys with Perthes' disease revealed by bioassay. A disease of growth transition?
Burwell RG; Vernon CL; Dangerfield PH; Hall DJ; Kristmundsdottir F
Clin Orthop Relat Res; 1986 Aug; (209):129-38. PubMed ID: 3731586
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin and the regulation of skeletal growth.
Elders MJ; Wingfield BS; McNatt ML; Lee JA; Hughes ER
Ann Clin Lab Sci; 1975; 5(6):440-51. PubMed ID: 1200618
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic-pituitary dysfunction in patients with craniopharyngioma.
Paja M; Lucas T; García-Uría J; Salamé F; Barceló B; Estrada J
Clin Endocrinol (Oxf); 1995 May; 42(5):467-73. PubMed ID: 7621564
[TBL] [Abstract][Full Text] [Related]
15. [Somatomedin activity and growth hormone secretion in children with idiopathic growth retardation (author's transl)].
Carrascosa A; Prevot C; Evain D; Czernichow P; Rappaport R
Arch Fr Pediatr; 1980 Oct; 37(8):515-9. PubMed ID: 7447606
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia as the first symptom of craniopharyngioma.
Maira G; Di Rocco C; Anile C; Roselli R
Childs Brain; 1982; 9(3-4):205-10. PubMed ID: 7105886
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Med Pediatr Oncol; 2003 Apr; 40(4):214-8. PubMed ID: 12555247
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
Cancer J; 2000; 6(6):388-93. PubMed ID: 11131489
[TBL] [Abstract][Full Text] [Related]
19. [A case of craniopharyngioma with hyperprolactinemia in postoperative course (author's transl)].
Miwa T; Yamamoto Y; Azuma S
No Shinkei Geka; 1981 Apr; 9(5):559-66. PubMed ID: 7242837
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma.
Bucher H; Zapf J; Torresani T; Prader A; Froesch ER; Illig R
N Engl J Med; 1983 Nov; 309(19):1142-6. PubMed ID: 6353237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
